Sign in

CIK 0001863127 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831476348
Phone
(619) 728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
  1. 4 Open-market buy Director bought 186,850 shares at $10.19 ($1,904,002)
  2. 4 Open-market buy Director bought 1,211,198 shares at an average $9.70 ($11,751,304)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Grant or award President and CEO acquired 1,241 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 1,238 shares (grant or award)
  12. 4 Open-market sale Director sold 5,401 shares at $13.76 ($74,324)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale Director sold 4,825 shares at $16.26 ($78,466)
  16. 4 Open-market sale Director sold 25,041 shares at an average $16.36 ($409,645)
  17. 4 Open-market sale Director sold 5,272 shares at $16.84 ($88,773)
  18. 4 Open-market buy Director bought 1,220,681 shares at $16.25 ($19,836,066)
  19. 4 Open-market sale Director sold 74,582 shares at an average $17.22 ($1,284,133)
  20. 4 Open-market sale Director sold 11,569 shares at an average $16.79 ($194,248)

Page 3 of 11 · 203 filings